Delayed sleep-wake phase disorder …

Bradley V Vaughn MD

Sleep Disorders

Updated 03.20.2024
Released 11.22.1993
Expires For CME 03.20.2027

Delayed sleep-wake phase disorder

Author: Bradley V Vaughn MD

See Contributor Disclosures

Editor: Antonio Culebras MD FAAN FAHA FAASM

Delayed sleep-wake phase disorder

In This Article

Quick Link

Introduction

Overview

Circadian rhythm issues are common and can impact health and quality of life. Delayed sleep-wake phase disorder (DSWPD) is characterized by late bedtime and wake times and an inherent delay of biological rhythms compared to the natural daylight. This pattern is frequently observed in adolescents and young adults and may cause chronic sleep deprivation, leading to compromise in school and work performance (40). Some investigators have considered delayed sleep-wake phase disorder as a marker or precursor for psychiatric and possibly neurologic issues. Delayed sleep-wake phase disorder may disguise itself as insomnia, attention deficit disorder, emotional or affective disorder, or maladjustment, and it can be somewhat similar to the schedule seen in restless legs syndrome. The delay in the body clock can be treated with a combination of lifestyle modifications, appropriately timed exposure to light, and melatonin.

Key points

	• Delayed sleep-wake phase disorder is a relatively common circadian rhythm sleep disorder; it usually begins in adolescence and is manifested as habitually delayed time of sleep onset and waking.
	• Delayed sleep-wake phase disorder may significantly impede academic and occupational achievements.
	• Delayed sleep-wake phase disorder must be distinguished from other sleep disorders as the treatment approach is different.
	• Treatment with appropriately timed melatonin and bright light, augmented with behavior and lifestyle modifications, may be effective.
	• Relapses after cessation of treatment are common.

Historical note and terminology

Delayed sleep-wake phase disorder was first described in 1979 by a group of researchers and clinicians from Montefiore Medical Center in New York and Stanford University School of Medicine (61). The current formal name established in the third edition of the International Classification of Sleep Disorders (ICSD-3tr) is delayed sleep-wake phase disorder (01). Prior names include delayed sleep phase syndrome and circadian rhythm sleep disorder, delayed sleep phase type.

Clinical manifestations

Presentation and course

	• The circadian rhythm influences many aspects of physiology.
	• The circadian rhythm in delayed sleep-wake phase disorder is shifted later when compared to the social norms. Thus, patients have trouble falling asleep at night and trouble waking in the morning.
	• Patients with delayed sleep-wake phase disorder have otherwise normal sleep except that the sleep occurs later in the night and waking occurs later in the morning or early afternoon.
	• Many patients have more delay in their schedule over the weekends, making Sunday night and Monday morning symptoms worse.
	• Individuals with delayed sleep phase disorder are more likely to have affective disorders and other detrimental health and behavioral effects.

The circadian rhythm is an intrinsic body clock that modulates a variety of physiologic processes to anticipate upcoming events and physiologically prepares for those events. Although every system in the body has a circadian rhythm, one manifestation is the sleep-wake cycle, and it is estimated that between 10% and 20% of genes oscillate in a circadian fashion. The circadian rhythm provides a stimulus for alerting. Typically, this alerting signal from the circadian rhythm increases throughout the morning, decreases between 2:00 PM and 4:00 PM (associated with an “afternoon dip” in alertness), and increases through late afternoon to peak later in the evening. The alerting drive then decreases through the night to reach a low in the early morning before a slow rise prior to the morning awakening. In patients with delayed sleep-wake phase disorder, the circadian rhythm is delayed when compared to the typical day-night schedule, and therefore, sleep onset and the natural wake time is delayed, usually by more than 2 hours, in relation to conventional or socially acceptable time. This results in difficulty with sleep-initiation and difficulty awakening at the desired time for societal activities. When able to sleep and wake unrestricted, these patients will fall asleep very late at night and then sleep until late morning or early afternoon. The quality and quantity of their sleep is otherwise normal; however, it occurs at a time that is delayed when compared to the societal norms. These patients will frequently suffer from difficulty falling asleep, excessive morning sleepiness, and chronic sleep deprivation while trying to adhere to typical school or work schedules. This may result in disrupted vocational or social functioning. The complaint of daytime sleepiness depends partially on sleep deprivation resulting from an attempt to get up at conventional hours. Adolescents with delayed sleep-wake phase disorder commonly fall asleep during morning classes. Morning sleepiness in delayed sleep-wake phase disorder is also attributable to the delayed position of the "sleepy" phase of the circadian sleep-wake rhythm. Those who do manage to arise on time for school or a daytime job are awakening in the middle of their endogenous "night."

Another common presenting complaint is inability to fall asleep at the desired time at night. Patients typically do not feel sleepy until well past the desired bedtime. It may be difficult to clinically distinguish delayed sleep-wake phase disorder from insomnia. Insomnia patients tend to complain of fatigue and sleepiness while trying to go to bed but may feel more awake once in bed. Those with delayed sleep-wake phase disorder do not notice this evening sleepiness nor do they note feeling sleepy until late into the night or morning. Some patients may suffer from both delayed sleep-wake phase disorder and insomnia.

Patients with delayed sleep-wake phase disorder often have worsening delay on weekends when there is less constraint on the sleep-wake schedule. Patients may sleep until late morning or early afternoon in an attempt to “catch up.” Falling asleep on Sunday night tends to be very difficult due to progressive delay in circadian rhythm during the weekend. In adolescents, the battle over bedtime often becomes a major source of conflict between children and parents.

Some patients may have the presenting symptoms of depression or anxiety. The delay in their bedtime and wake time may be perceived as a mechanism of avoidance and not a circadian rhythm disorder. In addition, the delayed schedule may be a contributing factor to the mood issues (20).

Prognosis and complications

• Patients with delayed sleep-wake phase disorder have a high rate of school and work tardiness and can frequently be labelled as lazy or depressed.

Even in the absence of major psychopathology, serious occupational, school, and social dysfunction are complications of delayed sleep-wake phase disorder, occurring in 4% of adolescent and young adults (15). The disorder appears slightly more prevalent in male (4.7%) than female (2.7) Norwegian adults ages 18 to 35 years (53). Tardiness at school or work, absenteeism, and daytime sleepiness are the common precipitants for evaluation (44). Delayed sleep-wake phase disorder can be mistaken for school refusal. Difficulty waking in the morning has resulted in job loss and disciplinary measures in the military. Patients with delayed sleep-wake phase disorder may be labeled as lazy or mentally ill by their families, peers, or superiors in the business or school environment, solely on the basis of their inability to awaken in the morning. Sleepiness due to chronic sleep deprivation may make driving dangerous.

Prognosis of delayed sleep-wake phase disorder depends on a variety of factors, including how much sleep the patient needs (short sleepers tend to do better), family support, and most of all, the motivation of the patient to change the timing of sleep. Waking a sleeping teenager can be an unpleasant or even violent experience for the parents of a delayed sleep-wake phase disorder patient. If the parent-teen relationship is a difficult one, the control of bedtime and waking can become a major battleground. For most people who develop a mild delay (1 to 2 hours) in their sleep phase, simple behavioral measures can help with resetting their body clocks. However, for many patients with more significant delayed sleep phase syndrome, long-term management with multiple strategies is needed to help keep their circadian rhythm in synchronization with society.

Emerging evidence suggests that appropriately functioning circadian rhythms contribute to wellbeing, health, and cognitive performance (46). Studies indicate that delayed sleep-wake phase tendencies are linked to multiple psychiatric and medical health risks, especially in adolescents and young adults (04). Children aged 11 to 13 years who sleep less than 9 hours had an adjusted odds ratio of over 3.3 for developing delayed sleep phase syndrome. This risk seemed primarily related to early mental health issues (25). Individuals with a preference for the evening are more prone to depression (03). Adults with attention deficit hyperactivity disorder tend to show a delay in melatonin secretion and circadian timing, and a subgroup of patients with bipolar disorder appear to present with delayed sleep phase (56; 11; 58). A delayed sleep tendency may predispose individuals to type 2 diabetes and metabolic syndrome (63). Understanding the role of the circadian rhythm in psychiatric and medical conditions may serve an important role in evaluating risk and treatment strategies for such disorders.

Clinical vignette

A 16-year-old patient presents to clinic with a chief complaint of difficulty falling asleep, inability to wake in time for school, and excessive daytime sleepiness. Over the past 2 years, the patient describes an inability to go to sleep at a normal time. He characterizes himself as a “night owl.” He will fall asleep around 2:00 AM each night. He reports that he does not feel sleepy until that time. If he lies in bed, he will not feel tired or sleepy until he falls asleep around 2:00 AM and he will struggle to wake up at 7:00 AM for school. To occupy his time at night, he will play video games or use his computer until he feels sleepy. On weekends, he will routinely go to bed between 2:00 AM and 4:00 AM and wake between noon and 2:00 PM. He reports feeling less sleepy on weekends. Due to his late bedtime, he has been unable to wake up in time for school on multiple occasions and is now receiving homebound education due to numerous missed days.

In addition to reviewing good sleep hygiene practices and taking the cell phone out of the bedroom at night, the patient was prescribed 0.5 mg of synthetic melatonin at 8:00 PM each night along with lifestyle modification to avoid late night light exposure by wearing blue-blocking sunglasses after 8:00 PM. He was instructed to move his bedtime and wake time earlier by 15 minutes each day. He was also instructed to get as much light exposure as possible upon awakening in the morning initially after 10:00 AM. Over the course of 3 weeks, his sleep cycle eventually began to shift, and the patient was instructed to advance the morning light in 15-minute increments. Over the next 6 weeks the patient was able to go to bed at 10:00 PM and wake at 7:00 AM. He was able to successfully transition back to school. He was instructed to maintain the same sleep-wake schedule on both weekdays and weekends and continue wearing the nighttime blue light blocking sunglasses and use of melatonin.

Biological basis

	• The circadian rhythm is inherent in every tissue of the body and influences many physiological processes to promote readiness of each organ system when typically needed.
	• This rhythm can be influenced by specific stimuli, such as bright light, activity, food, and social interactions.
	• The rhythm can become out of phase with the environment, especially if specific stimuli are present at times that can shift the circadian rhythm.

The circadian rhythm is based on a genetic feedback loop that approximates 24 hours. Due to being genetically based, this rhythm is ubiquitous in every tissue, and thus, it relies on a complex system to synchronize the rhythm in every cell. Although most synchronization is primarily achieved through the suprachiasmatic nucleus, the suprachiasmatic nucleus relies on several environmental clues to synchronize the body’s overall clock with the natural world. These clues are primarily related to bright light, activity, food, and social interaction, with the strongest being bright light influence. Timed delivery of these stimuli will change the circadian rhythm. Thus, delivery of these stimuli in the evening will delay the clock, whereas delivery of these stimuli in a typical morning advances the clock. In our adolescent years, our response to bright light in the evening appears to be more intense and even low levels of light may delay our ability to fall asleep. Some individuals may maintain this increased sensitivity, whereas others may have the genetic predisposition for their body clocks to be delayed when compared to the rest of the society.

Etiology and pathogenesis

Delayed sleep-wake phase disorder is due to a misalignment between the body’s endogenous circadian rhythm and the social environment. The alerting signal from the circadian rhythm persists past the time in which the patient should be sleeping, and likewise, there is a delay in the rise of the alerting signal in the morning, leading to delay in awakening. The mechanism underlying delayed sleep-wake phase disorder involves a delay in the timing of the circadian pacemaker. Proposed causes for this delay include decreased response to the phase-advancing effect of morning light, an increased responsiveness to the delaying effects of evening light, and a longer than average circadian cycle. Although the etiology is unknown in most cases, studies show a genetic predisposition in familial cases due to polymorphisms in circadian clock genes. Patients may also have increased light exposure and increased activities at night that likely play a role (27; 39). In addition, some evidence of increased susceptibility to evening environmental clues, either by age or genetics, may play a significant role for some patients (27). This may be exacerbated by the patient’s activity pattern.

In order to understand how this misalignment occurs, it is important to understand the mechanisms that establish and modulate the circadian rhythm.

All living organisms possess an inherent circadian rhythm. This near 24-hour cycle modulates a variety of physiologic and behavioral processes, such as sleep-wake cycle, body temperature, mood, hormone secretion, and many others. The paired suprachiasmatic nuclei (SCN) of the hypothalamus have been established as the “master clock” that sets the timing of the mammalian circadian system. The SCN is composed of 10,000 anterior ventromedial hypothalamic neurons that maintain a self-sustaining daily rhythm. This cycle is achieved through a complex system of timed gene expression that creates an autoregulatory feedback loop. A variety of genes are involved in this cycle, including Clock, Per, Bmal1, and Cry.

The biological clocks of normal humans of all ages have a natural endogenous circadian cycle of slightly more than 24 hours, generally about 24.2 hours. Therefore, the internal body clock must be adjusted on a daily basis to align with the 24-hour day, a process called entrainment. Entrainment involves using zeitgebers (German for “time givers”) to reset the internal clock slightly each day. Common zeitgebers include light, melatonin, food intake, social interaction, and exercise. Each of these factors can independently change the timing of the circadian pacemaker, thereby altering the time of all physiologic processes that are regulated on a circadian basis.

Light is the main zeitgeber for endogenous clocks in humans. The human circadian system is more sensitive to short-wave blue-green light than to long-wave red-spectrum light. The major afferent input to the SCN consists of a melanopsin-containing subset of photosensitive retinal ganglion cells whose axons synapse on SCN cells.

Human circadian system outline

Melatonin (upper right inset) is produced in the pineal gland. The production and secretion of melatonin is mediated largely by postganglionic retinal nerve fibers that pass through the retinohypothalamic tract to the suprachiasma...

This retinohypothalamic tract transmits nonvisual, light-dark information to the SCN, which is mediated through glutamate and pituitary cyclase-activating peptide (PACAP). In addition to a direct pathway, retinal ganglion cells also project to the intergeniculate leaflet of the lateral geniculate body, which in turn projects to the SCN. Neuropeptide Y and GABA are the main neurotransmitters. Other time clues appear to influence the SCN through serotonergic input from the brainstem raphe nuclei.

Key to understanding the zeitgebers is that the response of the circadian rhythm depends on when the stimulus is delivered. For example, light delivered prior to the temperature nadir (typically 4:00 AM in normal phase individuals) will cause a delay in the body clock. Light delivered after the body temperature nadir will advance the clock. Thus, for light therapy to be appropriately used, understanding the true timing of the circadian rhythm is essential. The temperature nadir is typically 1.5 to 2 hours before the undisturbed natural wake up time. Therefore, if a person is naturally waking at 11 AM without an alarm, the temperature nadir would most likely be between 9:00 and 9:30 AM.

Similar to light, melatonin also has a time-dependent effect on the phase of the circadian rhythm. However, melatonin has the opposite effect of light, such that melatonin delivered in the evening causes a phase advance whereas morning use may cause a mild phase delay. The SCN exhibit dense melatonin receptors, probably establishing a feedback mechanism for the sleep-wake cycle. Melatonin and potentially other factors such as light help synchronize the multitude of endogenous rhythms in the brain and other organs. Synchronization of these endogenous rhythms is important to optimal body function. Isolated delay in an endogenous rhythm has been implicated in individuals with nocturnal eating syndrome, which appears to be a delay in the feeding rhythm. Although appearing benign, in this disorder the timing of food intake can impact insulin sensitivity and metabolism (19).

Delayed sleep-wake phase disorder is theorized to develop due to multiple possible factors, including decreased response to the phase-advancing effect of morning light, an increased responsiveness to the delaying effects of evening light, and a longer than average circadian cycle. However, work shows that the magnitude of circadian shift with light exposure may be similar in adults regardless of age (28). This work, however, did not examine the potential influence of genetics. There are familial cases, indicating a genetic basis for delayed sleep-wake phase disorder. Susceptibility to delayed sleep-wake phase disorder may involve polymorphisms of the circadian gene Per3 and its promoter region (32). Variations in the Per2 gene, including the missense variant gene Rs35333999 commonly found in Europe and the missense variant p.Val1205Met found in a Japan population, are associated with later chronotypes (07; 38). Also, mutations in the Cyr gene have been implicated in one family with delayed sleep phase (42). Behavioral factors such as late-night light exposure through television, computer screens, and smartphones also play an important role.

Unfortunately, the other time clues of activity, social interaction, and food have not been studied. These may also have specific effects in particular ages, especially recognizing the synchronizing effects of stimuli such as food on the brain and other organ systems (10). Individuals with the majority of their calorie intake later in evening, known as nocturnal eating syndrome, frequently have features similar to delayed sleep phase syndrome (36).

Differential diagnosis

Delayed sleep-wake phase disorder must be distinguished from other common issues that cause insomnia or hypersomnia. Many individuals without delayed sleep phase, particularly adolescents, adopt late bedtime and awakening hours. They adjust promptly to temporary periods of sleep-onset delay due to late-night studying or work followed by oversleeping to recover (eg, on weekends) and do not develop chronically delayed sleep onset nor oversleep when they resume a more conventional schedule. Additionally, some individuals adopt a social jetlag that is exacerbated by late night screen time (65). The patient who can adapt to a strictly imposed schedule and sleep normally within 7 to 10 days probably does not have true delayed sleep phase. The chronic inability to advance the schedule is the hallmark of delayed sleep-wake phase disorder.

Chronic insomnia disorders, such as idiopathic insomnia and psychophysiological insomnia, will also have delayed sleep onset. These patients are typically tired and sleepy but are unable to fall asleep, unlike patients with delayed sleep-wake phase disorder, who typically report not feeling sleepy until late at night. Restless legs syndrome may cause delayed sleep but is easily distinguished clinically from delayed sleep-wake phase disorder based on clinical complaints of the need to move to improve the symptoms. The two disorders may often occur together. Late sleep onset may also occur in association with the onset of a major psychiatric illness, particularly the manic phase of bipolar disorder and in schizophrenic decompensation. A chronic pattern of sleep phase delay is sometimes seen in individuals avoiding social interaction (eg, personality disorders); a response to a rigidly imposed schedule may help narrow the differential diagnosis.

Morning sleepiness and hypersomnia are seen in a variety of disorders with inadequate or disrupted sleep. Insufficient sleep syndrome and those with long sleep time will often have morning sleepiness. Patients with insufficient sleep have less trouble falling asleep earlier and improve with the extension of the time dedicated to sleep. Similarly, disorders that can disrupt sleep, such as sleep-related breathing disorders and periodic limb movement disorder, can present with morning sleepiness and be confused with delayed sleep-wake phase disorder. Central causes of hypersomnolence, including narcolepsy, should be considered. Narcolepsy patients often describe difficulty with sleep initiation.

Some patients may present with the most pressing feature of delay in eating the majority of the calories. This disorder is called nocturnal eating syndrome and may occur with delayed sleep-wake phase disorder or have very similar features of a delay in sleep wake phase (36). The key distinction would be if the major symptom is related to the late eating, then the diagnosis would be nocturnal eating syndrome. Because patients with nocturnal eating syndrome may have a similar delay in the circadian rhythm, similar treatment may coincide.

Confusing conditions

Patients with delayed sleep-wake phase disorder may present with features of insomnia and excessive daytime sleepiness. Commonly, the patients focus on one of these issues, and the other issue is not felt to be as concerning, thus it is typically not mentioned. Because patients with circadian rhythm disorder can present with either insomnia or hypersomnia as a major complaint, patients with insomnia or hypersomnia need thorough questioning and possibly a sleep diary or actigraphy to determine the possible role the circadian rhythm may play.

Other circadian rhythm disorders can be confused with delayed sleep-wake phase disorder. Advanced sleep-wake phase disorder is associated with individuals falling asleep early in the evening and waking typically prior to 4:00 AM. Non-24-hour sleep wake disorder can commonly be confused with delayed sleep-wake phase disorder, but in patients with non-24-hour sleep wake disorder, their circadian rhythm continues to gradually move later each day, causing a cycling of symptoms across the day night period (see non-24-hour sleep wake disorder). Irregular sleep wake disorder is characterized by three major bouts of sleep across the 24-hour period. All of these may have features in common with delayed sleep-wake phase disorder and can become more obvious with the actigraphy or sleep logs.

Associated or underlying disorders

Affective disorders are frequently associated with circadian rhythm disorders. In adolescents and young adults, depression is associated with delayed sleep-wake phase disorder. These disorders appear to have a bidirectional interaction whereby delayed sleep phase increases the risk of developing affective disorder, and the affective disorder increases the risk of development of the delayed sleep phase (26). Other affective issues such as bipolar disorder and schizophrenia have been associated with delayed sleep-wake phase disorder (29; 30). Similarly, borderline personality disorder and those with obsessive compulsive disorder appear to have a preponderance of comorbid circadian issues including delayed sleep phase disorder (37; 12). Also, adults with attention deficit and hyperactivity disorder have a higher likelihood of delayed sleep phase (59). Thus, individuals with mood issues and learning difficulties should be asked about their sleep pattern, and those with delayed sleep phase should be asked about possible underlying mood issues. Those with mental disorders such as depression appear to have worse outcomes in relationship to cognitive functioning, social interactions, and quality of life (57). This may highlight the need for questioning and possible correction of the sleep phase to improve outcomes.

Another concern is overall healthy habits and cardiovascular health. Individuals with delayed sleep phase are more likely to smoke and to have less healthy habits, and they are less likely to engage and gain from healthy habits, such as exercise (21; 16). Individuals who are more likely to be sleep deprived because of their delayed schedule appear to also carry a higher risk of dyslipidemia and downstream arteriosclerotic issues (14).

Management

	• Timing of melatonin 4 to 6 hours in advance of bedtime is key to advancing the circadian rhythm.
	• Blue light blocking sunglasses used in the evening until bedtime may help in advancing the circadian rhythm.
	• Light therapy should be delivered after the temperature nadir, thus approximately around the undisturbed wake up time of the patient. Light therapy delivered prior to the temperature nadir will cause further delay of the circadian rhythm.

Treatments for delayed sleep-wake phase disorder aim to achieve sustained phase shift to synchronize the circadian sleep-wake signals to the desired sleep-wake schedule. This is achieved through a combination of behavioral modification and pharmacologic interventions. The main treatment approach involves timing of light exposure, exogenous melatonin, and chronotherapy. Although slow advancement of the bedtime and wake time can help advance the body clock, taking melatonin in the early evening and having exposure to bright light in the morning after the temperature nadir maintains the phase advancement better than providing a strict wake-time schedule (50; 02). General measures to improve sleep hygiene may help to consolidate and maintain the new schedule.

Timing of light exposure is a vital part of treatment. Light is the most important zeitgeber to the circadian oscillator. Bright light exposure has phase-shifting effects, with phase delay or advance following late evening or early morning exposure, respectively. In the first controlled human study, enhancement of the morning time cue with bright light (2500 lux full spectrum light between 7:00 AM and 9:00 AM) was helpful in 20 patients with delayed sleep-wake phase disorder (02). More studies followed that employed different protocols of light intensity and timing, including the use of blue light emitting glasses that appear to be helpful (31). Daily light exposure sessions are probably needed to maintain phase shift. However, two long-term studies showed that benefits did not persist (22). Because phase-response curves for melatonin and light are at nearly 180° phase angle difference to each other, it is possible to use combined light-melatonin treatment with proper timing of each in order to increase the success rate of the treatment of circadian rhythm disorders (43). An additional consideration is daylight savings time. The condition of sunlight exposure later in the evening may exacerbate the delay in the sleep-wake schedule. Reis and colleagues found that patients did better on standard time, compared to having daylight “later” in the schedule as in daylight savings time (47). Patients may need to wear blue light–blocking sunglasses when outside in the evening.

Phase-response curve to light and to exogenous melatonin

The y-axis shows the direction and relative magnitude of the phase shift produced by the administration of light (blue line) and melatonin (red line) at various times that are shown on the x-axis. The two x-axes show the time of m...

Many commercial light boxes are available, varying in design and light intensity. Longer periods of moderate intensity light may be more effective than a shorter exposure period of high intensity light.

Physiological doses of exogenous melatonin (less than 1 mg) were found to shift circadian phase and advance the time of sleep onset in as few as 5 days (54). A modest phase advancing effect of doses up to 5 mg of melatonin given in the evening was shown in patients with delayed sleep-wake phase disorder (02). Controlled-release melatonin was also effective in improving sleep in children with delayed sleep-wake phase disorder and neurodevelopmental disability (05). In one of the largest series reported to date (61 patients), evening melatonin was effective in 96.7%; however, the vast majority relapsed after melatonin was discontinued. Many patients relapsed a long time after melatonin wash out (2 months or more), and these patients tended to have milder delayed sleep-wake phase disorder than patients with immediate relapse (up to 1 week after discontinuing melatonin). The timing of melatonin administration seems to be more important than the dose (02); the largest phase advance is achieved when melatonin is administered 5 to 6 hours before the individual’s DLMO. The review and practice parameters of the American Academy of Sleep Medicine state that melatonin is indicated as a therapy for patients with delayed sleep-wake phase disorder (02). Similarly, a review of the use of melatonin for delayed sleep-wake phase disorder in children and adolescents showed relatively consistent results in reducing sleep latency by 22 to 60 minutes, with no relevant adverse effects (35). This response is also noted in children with some neurodevelopmental disorders (49). Some of the melatonin effect may be related to the underlying genetics. Magee and colleagues examined the response to melatonin 1 hour before the desired bedtime in individuals with delayed sleep phase disorder and subdivided the groups based on the Period 3 gene polymorphism (34). These investigators found those with PER 3 4/4 had greater subjective improvement in sleep latency. However, there were no significant differences when compared to other polymorphisms on objective sleep latency from actigraphy. The key to this work suggests that responses may be different based on the underlying genetic polymorphism, and further investigation of the relationship of polymorphisms and circadian responses is needed. The response may also vary depending on other underlying disorders. In patients with bipolar disorder and treatment with timed melatonin, one single-arm study found improvement in sleep time and efficiency in those with self-reported delayed sleep phase (13). Overall, melatonin seems promising in the treatment of delayed sleep-wake phase disorder, although its effect seems to last only as long as it is administered. Major issues such as the optimal timing and dose remain to be evaluated; the doses employed in various studies range from 0.3 to 5 mg. Long-term safety of melatonin also needs to be determined, although up to 1000 mg per day have been administered for 30 days without major side effects except drowsiness. This hormone is not currently approved in the United States, except as an investigational agent; it is available, however, as a nonprescription supplement, raising questions as to the standardization and purity of various preparations. The U.S. FDA approved ramelteon, a highly selective melatonin agonist with high affinity to melatonin MT1 and MT2 receptors, as a medication for insomnia. In preliminary studies ramelteon was shown to shift circadian phase in both animals and humans (02). This shift was also seen with low dose ramelteon in the 0.14 to 1.2 mg range and appears to shift individuals as much as 3 hours over 2 weeks (52). Another melatonin agonist, tasimelteon, was found to effectively shift a circadian phase and improve sleep in simulated jet lag as well as helping the free running circadian rhythm in non-24-hour sleep-wake rhythm disorder (45; 33). These may start an era of standardized melatonin agonist preparations with selective activity at various receptors, thus, enabling specific therapeutic effects. The dopamine blocking agent, agomelatine, also has demonstrated some benefit in advancing sleep phase in young adults. This compound is not approved in the United States but is available in Europe and Australia (64).

One approach is to combine melatonin therapy in the evening and providing light therapy in the morning. This approach was successful in advancing the DLMO in healthy subjects. Unfortunately, Cheng and colleagues showed in a systematic review of studies utilizing this combined therapy that in subjects with delayed sleep phase it produced no clear benefit (08). Thus, combining therapy may not be as beneficial as once thought.

Alternatively blocking blue light in the evening may be beneficial for advancing sleep phase in this population. In this small open label study, eight subjects with delayed sleep wake phase disorder wore blue light blocking glasses in the evening for 2 weeks and showed an average of 78 minutes of phase advance in DLMO and over 2 hour advance in their sleep onset time (18). In two other studies using morning exercise as the stimulus, subjects with delayed sleep phase also appeared to advance their phase with as little as 4 days of morning exercise (48).

Slowly advancing a patient’s circadian rhythm is most effective with a combination of avoiding late night light exposure, low-dose melatonin, and early morning light exposure, along with slowly moving bedtime and wake time by 10 to 15 minutes each day. Once the patient arrives at the appropriate sleep timing, it is imperative to maintain this schedule by avoiding bright light prior to bed and exposing themselves to bright morning light. Low-dose melatonin may be necessary to maintain the circadian phase.

Long-term success in the treatment of delayed sleep-wake phase disorder is probably difficult to achieve because it is unclear whether chronobiological interventions change the inherent tendency to relapse. To maintain a “normal” sleep-wake pattern, improving the sleep hygiene and adhering to a strict schedule are no less important than various interventions; these may prove difficult in the long run because lifestyle changes need to be maintained.

References

01: American Academy of Sleep Medicine. The International classification of sleep disorders, 3rd edition text revision. Darien, IL: American Academy of Sleep Medicine, 2023.
02: Auger RR, Burgess HJ, Emens JS, Deriy LV, Thomas SM, Sharkey KM. Clinical practice guideline for the treatment of intrinsic circadian rhythm sleep-wake disorders: advanced sleep-wake phase disorder (ASWPD), delayed sleep-wake phase disorder (DSWPD), non-24-hour sleep-wake rhythm disorder (N24SWD), and irregular sleep-wake rhythm disorder (ISWRD). An update for 2015: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 2015;11(10):1199-236. PMID 26414986
03: Bailey O, Combs D, Sans-Fuentes M, et al. Delayed sleep time in African Americans and depression in a community-based population. J Clin Sleep Med 2019;15(6):857-64. PMID 31138383
04: Baron KG, Reid K. Circadian misalignment and health. Int Rev Psychiatry 2014;26(2):139-54. PMID 24892891
05: Bruni O, Alonso-Alconada D, Besag F, et al. Current role of melatonin in pediatric neurology: clinical recommendations. Eur J Paediatr Neurol 2015;19:122-33. PMID 25553845
06: Burgess HJ, Park M, Wyatt JK, Fogg LF. Home dim light melatonin onsets with measures of compliance in delayed sleep phase disorder. J Sleep Res 2016;25:314-7. PMID 26847016
07: Chang AM, Duffy JF, Buxton OM, et al. Chronotype genetic variant in PER2 is associated with intrinsic circadian period in humans. Sci Rep 2019;9(1):5350. PMID 30926824
08: Cheng DCY, Ganner JL, Gordon CJ, Phillips CL, Grunstein RR, Comas M. The efficacy of combined bright light and melatonin therapies on sleep and circadian outcomes: A systematic review. Sleep Med Rev 2021;58:101491. PMID 33962317
09: Chinoy ED, Duffy JF, Czeisler CA. Unrestricted evening use of light‐emitting tablet computers delays self‐selected bedtime and disrupts circadian timing and alertness. Physiol Rep 2018;6(10):e13692. PMID 29845764
10: Consens FB. Circadian rhythm sleep-wake disorders. Continuum (Minneap Minn) 2023;29(4):1149-66. PMID 37590827
11: Coogan AN, McGowan NM. A systematic review of circadian function, chronotype and chronotherapy in attention deficit hyperactivity disorder. Atten Defic Hyperact Disord 2017;9(3):129-47. PMID 28064405
12: Cox RC, Olatunji BO. Delayed circadian rhythms and insomnia symptoms in obsessive-compulsive disorder. J Affect Disord 2022;318:94-102. PMID 36057288
13: Cruz-Sanabria F, Faraguna U, Violi M, et al. Effects of exogenous melatonin on sleep and circadian rhythm parameters in bipolar disorder with comorbid delayed sleep-wake phase disorder: an actigraphic study. J Psychiatr Res 2023;165:96-104. PMID 37487294
14: Csoma B, Bikov A. The role of the circadian rhythm in dyslipidaemia and vascular inflammation leading to atherosclerosis. Int J Mol Sci 2023;24(18):14145. PMID 37762448
15: Danielsson K, Markström A, Broman JE, von Knorring L, Jansson-Fröjmark M. Delayed sleep phase disorder in a Swedish cohort of adolescents and young adults: prevalence and associated factors. Chronobiol Int 2016;33(10):1331-9. PMID 27537980
16: Dial MB, Malek EM, Cooper AR, et al. Social jetlag impairs exercise volume and attenuates physiological and metabolic adaptations to voluntary exercise training. J Appl Physiol (1985) 2024. [Epub ahead of print] PMID 38450426
17: Eastman CI, Suh C, Tomaka VA, Crowley SJ. Circadian rhythm phase shifts and endogenous free-running circadian period differ between African-Americans and European-Americans. Sci Rep 2015;5:8381. PMID 25670162
18: Esaki Y, Kitajima T, Ito Y, et al. Wearing blue light-blocking glasses in the evening advances circadian rhythms in the patients with delayed sleep phase disorder: An open-label trial. Chronobiol Int 2016;33(8):1037-44. PMID 27322730
19: Flanagan A, Bechtold DA, Pot GK, Johnston JD. Chrono-nutrition: From molecular and neuronal mechanisms to human epidemiology and timed feeding patterns. J Neurochem 2021;157(1):53-72. PMID 33222161
20: Futenma K, Takaesu Y, Komada Y, et al. Delayed sleep-wake phase disorder and its related sleep behaviors in the young generation. Front Psychiatry 2023;14:1174719. PMID 37275982
21: Ghotbi N, Rabenstein A, Pilz LK, Rüther T, Roenneberg T. Chronotype, social jetlag, and nicotine use. J Biol Rhythms 2023;38(4):392-406. PMID 37345295
22: Gomes JN, Dias C, Brito RS, et al. Light therapy for the treatment of delayed sleep-wake phase disorder in adults: a systematic review. Sleep Sci 2021;14(2):155-63. PMID 34381579
23: Hartstein LE, Behn CD, Akacem LD, Stack N, Wright KP Jr, LeBourgeois MK. High sensitivity of melatonin suppression response to evening light in preschool-aged children. J Pineal Res 2022;72(2):e12780. PMID 34997782
24: Hartstein LE, Diniz Behn C, Wright KP Jr, Akacem LD, Stowe SR, LeBourgeois MK. Evening light intensity and phase delay of the circadian clock in early childhood. J Biol Rhythms 2023;38(1):77-86. PMID 36415902
25: Hysing M, Harvey AG, Stormark KM, Pallesen S, Sivertsen B. Precursors of delayed sleep phase in adolescence: a population-based longitudinal study. Sleep 2018;41(11). PMID 30203021
26: Jaakallio P, Kuula L, Pesonen AK. Temporal pathways between circadian rhythm, depression and anxiety in the transition from adolescence to early adulthood. J Affect Disord 2024;350:656-64. PMID 38244801
27: Joo EY, Abbott SM, Reid KJ, et al. Timing of light exposure and activity in adults with delayed sleep-wake phase disorder. Sleep Med 2017;32:259-65. PMID 27964860
28: Kim KL, Weissman AB, Puzia ME, et al. Circadian phase preference in pediatric bipolar children. J Clin Med 2014;3(1):255-66. PMID 26237260
29: Kirlioglu SS, Balcioglu YH. Chronobiology revisited in psychiatric disorders: from a translational perspective. Psychiatry Investig 2020;17(8):725-43. PMID 32750762
30: Kuula L, Halonen R, Lipsanen J, Pesonen AK. Adolescent circadian patterns link with psychiatric problems: A multimodal approach. J Psychiatr Res 2022;150:219-26. PMID 35397335
31: Li D, Fang P, Liu H, et al. The clinical effect of blue light therapy on patients with delayed sleep-wake phase disorder. Nat Sci Sleep 2022;14:75-82. PMID 35082544
32: Liu C, Tang X, Gong Z, Zeng W, Hou Q, Lu R. Circadian rhythm sleep disorders: genetics, mechanisms, and adverse effects on health. Front Genet 2022;13:875342. PMID 35571019
33: Lockley SW, Dressman MA, Licamele L, et al. Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials. Lancet 2015;386(10005):1754-64. PMID 26466871
34: Magee M, Sletten TL, Murray JM, et al. A PERIOD3 variable number tandem repeat polymorphism modulates melatonin treatment response in delayed sleep-wake phase disorder. J Pineal Res 2020;69(4):e12684. PMID 32682347
35: Mantle D, Smits M, Boss M, Miedema I, van Geijlswijk I. Efficacy and safety of supplemental melatonin for delayed sleep-wake phase disorder in children: an overview. Sleep Med X 2020;2:100022. PMID 33870175
36: Matsui K, Komada Y, Nishimura K, Kuriyama K, Inoue Y. Prevalence and associated factors of nocturnal eating behavior and sleep-related eating disorder-like behavior in Japanese young adults: results of an internet survey using Munich parasomnia screening. J Clin Med 2020;9(4):1243. PMID 32344700
37: McGowan NM, Saunders KEA. The emerging circadian phenotype of borderline personality disorder: mechanisms, opportunities and future directions. Curr Psychiatry Rep 2021;23(5):30. PMID 33835306
38: Miyagawa T, Hida A, Shimada M, et al. A missense variant in PER2 is associated with delayed sleep–wake phase disorder in a Japanese population. J Hum Genet 2019;64(12):1219-25. PMID 31527662
39: Moderie C, Van der Maren S, Dumont M. Circadian phase, dynamics of subjective sleepiness and sensitivity to blue light in young adults complaining of a delayed sleep schedule. Sleep Med 2017;34:148-55. PMID 28522084
40: Narala B, Ahsan M, Ednick M, Kier C. Delayed sleep wake phase disorder in adolescents: an updated review. Curr Opin Pediatr 2024;36(1):124-32. PMID 38054481
41: Paine SJ, Fink J, Gander PH, Warman GR. Identifying advanced and delayed sleep phase disorders in the general population: a national survey of New Zealand adults. Chronobiol Int 2014;31(5):627-36. PMID 24548144
42: Patke A, Murphy PJ, Onat OE, et al. Mutation of the human circadian clock gene CRY1 in familial delayed sleep phase disorder. Cell 2017;169(2):203-15. PMID 28388406
43: Paul MA, Gray GW, Lieberman HR, et al. Phase advance with separate and combined melatonin and light treatment. Psychopharmacology 2011;214:515–23. PMID 21069516
44: Rajaratnam SMW, Licamele L, Birznieks G. Delayed sleep phase disorder risk is associated with absenteeism and impaired functioning. Sleep Health 2015;1(2):121-7. PMID 29073375
45: Rajaratnam SM, Polymeropoulos MH, Fisher DM, et al. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. Lancet 2009;373(9662):482-91. PMID 19054552
46: Ramkisoensing A, Meijer JH. Synchronization of biological clock neurons by light and peripheral feedback systems promotes circadian rhythms and health. Front Neurol 2015;6:128. PMID 26097465
47: Reis C, Pilz LK, Kramer A, Lopes LV, Paiva T, Roenneberg T. The impact of daylight-saving time (DST) on patients with delayed sleep-wake phase disorder (DSWPD). J Pineal Res 2023;74(4):e12867. PMID 36942915
48: Richardson CE, Gradisar M, Short MA, Lang C. Can exercise regulate the circadian system of adolescents? Novel implications for the treatment of delayed sleep-wake phase disorder. Sleep Med Rev 2017;34:122-9. PMID 27546185
49: Salanitro M, Wrigley T, Ghabra H, et al. Efficacy on sleep parameters and tolerability of melatonin in individuals with sleep or mental disorders: A systematic review and meta-analysis. Neurosci Biobehav Rev 2022;139:104723. PMID 35691474
50: Saxvig IW, Wilhelmsen-Langeland A, Pallesen S, Vedaa O, Nordhus IH, Bjorvatn B. A randomized controlled trial with bright light and melatonin for delayed sleep phase disorder: effects on subjective and objective sleep. Chronobiol Int 2014;31(1):72-86. PMID 24144243
51: Sharkey KM, Boni GM, Quattrucci JA, Blatch S, Carr SN. Women with postpartum weight retention have delayed wake times and decreased sleep efficiency during the perinatal period: a brief report. Sleep Health 2016;2(3):225-8. PMID 27857964
52: Shimura A, Kanno T, Inoue T. Ultra-low-dose early night ramelteon administration for the treatment of delayed sleep-wake phase disorder: case reports with a pharmacological review. J Clin Sleep Med 2022;18(12):2861-5. PMID 35929592
53: Sivertsen B, Harvey AG, Gradisar M, Pallesen S, Hysing M. Delayed sleep-wake phase disorder in young adults: prevalence and correlates from a national survey of Norwegian university students. Sleep Med 2021;77:184-91. PMID 33097403
54: Sletten TL, Magee M, Murray JM, et. al. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: a double-blind, randomised clinical trial. PLoS Med 2018;15(6):e1002587. PMID 29912983
55: Smith MT, McCrae CS, Cheung J, et al. Use of actigraphy for the evaluation of sleep disorders and circadian rhythm sleep-wake disorders: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 2018;14(7):1231-7. PMID 29991437
56: Steinan MK, Morken G, Lagerberg TV, et al. Delayed sleep phase: an important circadian subtype of sleep disturbance in bipolar disorders. J Affect Disord 2016;191:156-63. PMID 26655861
57: Takaesu Y, Kanda Y, Nagahama Y, et al. Delayed sleep-wake rhythm is associated with cognitive dysfunction, social dysfunction, and deteriorated quality of life in patients with major depressive disorder. Front Psychiatry 2022;13:1022144. PMID 36419978
58: Talih F, Gebara NY, Andary FS, Mondello S, Kobeissy F, Ferri R. Delayed sleep phase syndrome and bipolar disorder: Pathogenesis and available common biomarkers. Sleep Med Rev 2018;41:133-40. PMID 29534856
59: van Andel E, Bijlenga D, Vogel SWN, Beekman ATF, Kooij JJS. Attention-deficit/hyperactivity disorder and delayed sleep phase syndrome in adults: a randomized clinical trial on the effects of chronotherapy on sleep. J Biol Rhythms 2022;37:673-89. PMID 36181304
60: Varcoe TJ, Gatford KL, Kennaway DJ. Maternal circadian rhythms and the programming of adult health and disease. Am J Physiol Regul Integr Comp Physiol 2018;314(2):R231-41. PMID 29141950
61: Weitzman ED, Czeisler CA, Coleman RM, Dement W, Richardson G, Pollak CP. Delayed sleep phase syndrome: a biological rhythm disorder. Sleep Res 1979;8:221.
62: Wilson J 4th, Reid KJ, Braun RI, Abbott SM, Zee PC. Habitual light exposure relative to circadian timing in delayed sleep-wake phase disorder. Sleep 2018;41(11). PMID 30423177
63: Yu JH, Yun CH, Ahn JH, et al. Evening chronotype is associated with metabolic disorders and body composition in middle-aged adults. J Clin Endocrinol Metab 2015;100:1494-502. PMID 25831477
64: Yu Y, Chen Y, Ma L, et al. Efficacy of agomelatine with cognitive behavioral therapy for delayed sleep-wake phase disorder in young adults: A randomized controlled study. Behav Sleep Med 2022;1-11. PMID 36263691
65: Yue L, Cui N, Jiang L, Cui N. Screen use before sleep and emotional problems among adolescents: preliminary evidence of mediating effect of chronotype and social jetlag. J Affect Disord 2023;328:175-82. PMID 36806592

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Author

Bradley V Vaughn MD

Dr. Vaughn of UNC Hospital Chapel Hill and University of North Carolina School of Medicine has no relevant financial relationships to disclose.
See Profile

Editor

Antonio Culebras MD FAAN FAHA FAASM

Dr. Culebras of SUNY Upstate Medical University at Syracuse has no relevant financial relationships to disclose.
See Profile

Former Authors

Daniel Wagner MD
Baruch El-Ad MD
Sujay Kansagra MD

Patient Profile

Age range of presentation: 6 to 64 years
Sex preponderance: male=female
Heredity: heredity may be a factor
Population groups selectively affected: none selectively affected
Occupation groups selectively affected: none selectively affected

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Delayed sleep-wake phase disorder

Associated Disorders

Circadian rhythm sleep disorder
Depression
Insufficient sleep syndrome
Personality disorder
Psychopathology
- Sleep deprivation

Differential Diagnosis

idiopathic insomnia
psychophysiological insomnia
restless legs syndrome
major psychiatric illness
manic phase of bipolar disorder
- schizophrenic decompensation
- personality disorders
- insufficient sleep syndrome
- behavioral insomnias of childhood
- insomnia due to mental condition
- sleep-related breathing disorders
- periodic limb movement disorder
- anxiety
- somatoform
- sleep-initiation insomnia
- obstructive sleep apnea
- other sleep disorders causing insomnia
- narcolepsy

Also Relevant

Advanced sleep-wake phase disorder
Insomnia
Insufficient sleep syndrome
Pharmacological treatment of insomnia
Sleep and depression
- Sleep and headaches
- Sleep and mental disorders
- Sleep disorders

Clinical Categories

Sleep Disorders

Patient Handouts

Web References

Clinical Trials

NIH: Sleep Disorders

Delayed sleep-wake phase disorder …

Delayed sleep-wake phase disorder

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Associated or underlying disorders

Diagnostic workup

Management

Special considerations

Pregnancy

Media

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

Telehealth and cognitive behavioral therapy for insomnia (CBT-I)

NonREM parasomnias

Neurologic disorders associated with obesity

Hypersomnolence

Sleep disorders in women

Sleep, stroke, and vascular dementia

Parasomnia overlap disorder and status dissociatus

Stimulant-dependent sleep disorder

Delayed sleep-wake phase disorder

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Associated or underlying disorders

Diagnostic workup

Management

Special considerations

Pregnancy

Media

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Telehealth and cognitive behavioral therapy for insomnia (CBT-I)

NonREM parasomnias

Neurologic disorders associated with obesity

Hypersomnolence

Sleep disorders in women

Sleep, stroke, and vascular dementia

Parasomnia overlap disorder and status dissociatus

Stimulant-dependent sleep disorder

This is an article preview.
Start a Free Account
to access the full version.